Project Grant R35NS132231
Award Date
9/1/24
Completion Date
8/31/32
Dollars Obligated
$885K
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This $213,284 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research to characterize unique sodium currents in human dorsal root ganglia neurons. The primary objectives are to determine whether human nociceptors (pain-sensing neurons) display resurgent sodium currents, if these currents are potentiated by...
This federal Project Grant award of $915,281 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research to elucidate the properties and functions of different classes of mechanosensory neurons, define the organizational logic of touch circuits, investigate the role of mechanotransduction in somatosensory development, and determine the basis of aberrant touch...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to explore the unknown function of the LRRC55 protein in pain processing. The $444,125 award, spanning from September 2024 to August 2026, will support research conducted by Duke University to: Delineate the role of LRRC55 in chronic pain behaviors using genetically modified mice; 2) Quantify functional changes in LRRC55...
This $387,662 federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research at Duke University to elucidate the molecular mechanisms of cellular mechanosensitivity. The project aims to develop biosensors to study how protein phosphorylation affects the mechanical state of linker proteins, identify key mediators of mechanosensitivity, and evaluate the role of these...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will fund research to investigate a novel, non-opioid spinal analgesic mechanism involving the neurotensin receptor 2 (NTSR2) and voltage-gated calcium channels Cav2.3 and Cav2.2. The total award amount is $664,772, with a project period from February 1, 2025 to November 30, 2029. The research aims...
The Project Grant award R61NS133704, totaling $1,846,202.00, was provided by the National Institute of Neurological Disorders and Stroke under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to Duke University. The primary objective is to develop potent, selective, and peripherally-restricted antagonists of the adrenergic receptor beta-3 (ADRB3) for the treatment of chronic primary pain conditions affecting over 100 million people. This will involve: 1) developing novel ADRB3...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), funded under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the regulation of inflammation by nociception (pain sensation) at barrier tissues such as the skin. The $1,656,000 award to the Scripps Research Institute aims to uncover how endogenous opioid signaling mediates communication between sensory neurons and immune cells to regulate immune homeostasis in the...
This federal Project Grant award, with ID R01NS139529, is funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $597,999 award, spanning from March 15, 2025 to January 31, 2030, supports research by the University of Pittsburgh to investigate the neural circuitry underlying mechanical allodynia, a debilitating condition where normally innocuous touch becomes...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to understand how the dorsal column nuclei (DCN) in the brainstem contribute to touch-evoked pain in persistent pain states. The $130,610 award, effective July 15, 2024 through June 30, 2026, will enable the principal investigator at Rutgers, The State...
This $2,569,851 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Abuse and Addiction Research Programs (CFDA 93.279), supports research to investigate how the PD-L1/PD-1 immune checkpoint pathway controls physiological and pathological pain, as well as opioid analgesia, through neuronal, immune, and glial mechanisms. The project aims to validate the actions of PD-L1 and the checkpoint inhibitor nivolumab on neuroinflammation and...